https://www.bloomberg.com/news/newsletters/2025-09-03/doctor-campaigns-to-let-dying-take-psychedelics-magic-mushrooms
One Doctor’s Campaign to Let the Dying Take Psychedelics

Back during the cannabis legalization campaigns, I said that when Bloomberg was reporting on cannabis, prohibition was already on the way out.

I'm seeing the same thing happen with psychedelic mushrooms.

It's already decriminalized in a lot of places where the cannabis legalization groups had simply flipped to psilocybin.

#cannabis #psilocybin #magicmushrooms #psychedelics

https://psychedelicmentalhealth.net/spotlight-psychedelics-and-mental-health-reimagining-care-through-science-insight-and-compassion-mikellides-et-al-2025/ Spotlight: Psychedelics and mental health: reimagining care through science, insight, and compassion (Mikellides, et al, 2025) "These substances...function as adjuncts to intensive psychotherapeutic processes. Training therapists and establishing ethical, evidence-based protocols is essential...Ketamine’s entry into psychiatric practice has paved the way for psychedelics." #ketamine #psychedelicresearch #psychedelics #mentalhealth #psychedelictherapy #mdma #psilocybin
Spotlight: Psychedelics and mental health: reimagining care through science, insight, and compassion (Mikellides, et al, 2025)

"These substances are not stand-alone medications; rather, they function as adjuncts to intensive psychotherapeutic processes. Training therapists and establishing ethical, evidence-based protocols is essential."

Psychedelic Institute of Mental Health & Family Therapy

MICRODOSING

Not tryin’ to get high.
Just tryin’ to get by.

#psilocybin #shrooms

https://psychedelicmentalhealth.net/psilocybin-for-post-traumatic-stress-disorder/ Spotlight: Investigating the safety and tolerability of single-dose psilocybin for post-traumatic stress disorder: A nonrandomized open-label clinical trial (McGowan, et al, 2025) "COMP360 #psilocybin administered in a single session with psychological support was found to be generally well-tolerated and without serious risk to safety... treatment associated with rapid, sustained reduction in #PTSD symptoms, improved functioning and quality of life to 12 weeks"
Spotlight: Investigating the safety and tolerability of single-dose psilocybin for post-traumatic stress disorder: A nonrandomized open-label clinical trial (McGowan, et al, 2025)

"In this trial, COMP360 psilocybin administered in a single session with psychological support was found to be generally well-tolerated and without serious risk to safety... treatment associated with rapid, sustained reduction in PTSD symptoms, improved functioning and quality of life to 12 weeks"

Psychedelic Institute of Mental Health & Family Therapy

#Psilocybin: »I found that the best antidepressant effects come from me taking between 6-8g of good quality cubensis. However this sort of dose is only for somebody extremely experienced with the headspace. Those high doses have been life changing to me. Taking a strong dose like that every two weeks annihilated thirteen years of suicidal depression, addiction and anxiety. I even accidentally quit smoking. I absolutely fell in life all over again. Simple beautiful. …

#LSD

https://psychedelicmentalhealth.net/spotlight-brain-changes-associated-with-depression-treatment-a-meta-analysis/ Meta-analysis of data from 302 depressed subjects yielding 87 foci across 18 experiments examining various depression treatments including pharmacology, psychotherapy, electroconvulsive therapy, psilocybin, and ketamine with brain activity measures in response to emotion tasks in the scanner. #ketamine #psilocybin #psychotherapy #neuroscience #brains #depression #mentalhealth
Spotlight: Brain changes associated with depression treatment: a meta-analysis

Meta-analysis of data from 302 depressed subjects yielding 87 foci across 18 experiments examining various depression treatments including pharmacology, psychotherapy, electroconvulsive therapy, psilocybin, and ketamine with brain activity measures in response to emotion tasks in the scanner.

Psychedelic Institute of Mental Health & Family Therapy
In recent years, numerous scientific studies have shown psilocybin to be a promising treatment for therapy-resistant depression. #mentalhealth #psychedelics #psilocybin #depression https://institutopsicodelico.org/terapia-asistida-con-psilocibina/programa-de-uso-compasivo-para-psilocibina
Programa de uso compasivo para la psilocibina posible por primera vez en Alemania — Instituto Psicodélico

…aprobación para la psilocibina para la depresión resistente al tratamiento en Alemania. En el futuro, los pacientes individuales podrán recibir el fármaco en casos excepcionales justificados.

Instituto Psicodélico
A Study From Emory University Finds That Psilocybin 🍄, a Compound Found in Psychedelic Mushrooms 🌈, Increases the Longevity of Human Fibroblast Cells by 57% ⏳✨

Read Full Article

#Psilocybin #PsychedelicResearch #Longevity #EmoryUniversity #HealthScience https://www.fascinatingworld.org/post/could-these-special-mushrooms-make-humans-live-longer
Reenviado desde Science News
(https://t.me/experienciainterdimensional/8807)
Could These Special Mushrooms Make Humans Live Longer?

A specific compound found in psychedelic mushrooms may have properties that reduce aging in humans and increase longevity. Called psilocybin

Fascinating World Media
Spotlight: Long-term benefits of single-dose psilocybin in depressed patients with cancer (Agrawal, et al, 2025)

"These findings demonstrate robust antidepressive activity from a single 25 mg dose of psilocybin combined with psychotherapy and suggest a potentially paradigm-changing alternative to traditional antidepressants requiring further study."

Psychedelic Institute of Mental Health & Family Therapy